![]() |
||
|
|
Hypertension Diagnostics' CVProfilor® DO-2020 System Featured in Medical Bulletin Sent to American Academy of Family Physicians ST. PAUL, MN – October 2, 2001 – Hypertension Diagnostics, Inc. (NASDAQ SmallCap: HDII) announced today that a detailed article describing its primary product, the CVProfilor® DO-2020 CardioVascular Profiling System, is featured in the October 2001 issue of the Medco Forum®. |
|
|
The mailing of this medical product bulletin was
scheduled as a prelude to the AAFP Annual Scientific Assembly being held
in Atlanta,
View
.pdf version of the Bulletin Hypertension Diagnostics, Inc. designs, develops,
manufactures and markets proprietary cardiovascular profiling systems for
medical applications and clinical research.
These systems are marketed to physicians, other health care
professionals and researchers by a direct sales force and via distributors
throughout the world. In addition to
providing blood pressure values, the systems non-invasively detect subtle
changes in the compliance or elasticity of both large and small arteries
which is a unique feature of HDI’s technology. Forward-looking statements in this press release are made
under the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. The Company
wishes to caution readers not to place undue reliance on any
forward-looking statements and to recognize that the statements are not a
prediction of actual future results. Actual
results could differ materially from those presented and anticipated in
the forward-looking statements due to the risks and uncertainties set
forth in the Company’s 2000 Annual Report on Form 10-KSB, as amended,
under the caption “Risk Factors,” as well as others not now
anticipated. CVProfilor is a registered trademark of Hypertension Diagnostics, Inc. Investor Relations: Jens Dalsgaard and Tony Altavilla, Return
to the Main HDI Newsroom
|
||
|
Copyright © 2007 Hypertension Diagnostics, Inc |
||